The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) represents the innovative biopharmaceutical industry across the globe. Over 2 million employees working in the research-based pharmaceutical industry discover, develop, and deliver medicines and vaccines that improve the life of patients worldwide.

Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve patients’ lives. To drive new and existing collaborations to support the Sustainable Development Goals (SDGs), with a particular focus on "SDG 17: Partnership for The Goals", IFPMA hosts Global Health Progress - a knowledge hub highlighting over 200 collaborations between the innovative biopharmaceutical industry and more than 850 partners to support the SDGs.”

Objectives:

At IFPMA they advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.

Who they are:

They represent research-based biopharmaceutical companies and regional and national associations across the world.

How they work:

They facilitate collaboration, dialogue, and understanding within their industry and with other global players in the health community.

What they do:

They bring the industry and broader health community together to foster innovation, promote resilient regulatory systems and high standards of quality, uphold ethical practices, and advocate sustainable health policies to meet global needs.

WHY IFPMA

There are many challenges in public health policy for current and future generations. To play an effective role in advancing these policies, the research-based biopharmaceutical industry needs an informed and credible voice in the conversation with the global health community. That voice is IFPMA.